Notice of Postal Ballot
Jubilant Life Sciences Ltd has informed BSE that the members of the Company will consider to approve the resolutions, by way of Postal Ballot.07-08-2014
07-08-2014
Presentation
Jubilant Life Sciences Ltd has submitted to BSE a copy of Presentation for the period ended June 30, 2014.05-08-2014
Financial Results with Results Press Release & Limited Review for June 30, 2014
Jubilant Life Sciences Ltd has informed BSE about the Financial Results, Results Press Release & a copy of the Limited Review Report for the period ended June 30, 2014.05-08-2014
Closure of Trading Window
Jubilant Life Sciences Ltd has informed BSE that a Board Meeting will be held on August 05, 2014, inter alia, to consider and approve Unaudited Financial Results of the Company for the quarter ended June 30, 2014.Further, as per the Companys Insider Trading Code, the Trading Window for dealing in the securities of the Company would remain closed for all Directors/Officers/Designated Employees of the Company from July 29, 2014 to August 06, 2014 (both days inclusive).25-07-2014
Shareholding Pattern For June 30, 2014
Jubilant Life Sciences Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.11-07-2014
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Jubilant Stock Holding Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE30-06-2014
Jubilant Life Sciences announces price increase of 9% for Niacinamide
Jubilant Life Sciences Ltd has informed BSE regarding a Press Release dated June 12, 2014, titled, "Jubilant Life Sciences announces price increase of 9% for Niacinamide".12-06-2014
Details as per Clause 20
Jubilant Life Sciences Ltd has informed BSE about the year ended March 31, 2014 as per Clause 20 of the Listing Agreement.26-05-2014
IFC's $147.5 million Package to Jubilant Pharma to Expand Access to Affordable Pharmaceuticals
Jubilant Life Sciences Ltd has informed BSE regarding a Press Release dated May 26, 2014, titled "IFC's $147.5 million Package to Jubilant Pharma to Expand Access to Affordable Pharmaceuticals"26-05-2014
Board recommends Dividend
Jubilant Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2014, inter alia, has recommended a dividend of Rs. 3 per equity shares of Rs. 1 fully paid up amounting to Rs. 5590 lacs, subject to approval in the Annual General Meeting.26-05-2014